According to new study women who experience hormone therapy for menopausal symptoms such as hot flashes can not only boost bone mass, but also can recover bone structure. According to preceding studies, menopausal hormone therapy can have positive impact on bone mineral density.
The new study established that menopausal hormone therapy also can get better bone mass and structure and that the bone health benefits persist for at least two years following women stop treatment.
Lead author Georgios Papadakis from the Lausanne University Hospital in Switzerland has conveyed that, when used specifically, in postmenopausal women younger than 60-years-old for whom the advantages outweigh risks, menopausal hormonal therapy is effectual for both the prevention and treatment of osteoporosis.
Osteoporosis is a progressive situation in which bones become structurally weak and are more probable to fracture or break. Menopause, which typically occurs when a woman is in her 40s or 50s, considerably speeds bone loss.
For the study, the players conducted a cross-sectional psychoanalysis on 1,279 women aged 50 to 80. The investigators established superior trabecular bone scores — used to forecast fracture risk in post-menopausal women — in those who used the therapy, compared to women who had never used it.
Precedent users of the therapy exhibited superior bone mass density and a trend for higher bone microarchitecture values compared to women who had never used menopausal hormone therapy. The researchers’ ahs also further noticed that, the study can help optimise the use of menopausal hormone treatment in menopausal women at risk of osteoporosis.